PPT-CONFERENCE ON RETROVIRUSES

AND OPPORTUNISTIC INFECTIONS CROI 2023 1923 FEBRUARY 2023 Faculty Pedro Cahn BuenosAires Argentina Anton Pozniak London UK François Raffi Nantes France Long Acting Therapies. 0 18May08 1040 Page 1 This sequence diagram was generated with EventStudio System Designer 40 httpwwwEventHelixcomEventStudio Copyright 2008 EventHelixcom Inc All Rights Reserved The EventStudio source files for this document can be downloaded from The conference themes will cover the major thrust areas of tissue engineering like biomaterials structures and models nanotechnology and nanobiotechnology for tissue engineering applications biocompatibility and toxicology aspects of biomaterials sc Template for CV. PHOTO. Prof. . . Nithyanand. . Prabhu. Institute/Company:- Indian Institute of technology, Bombay. Fields of Interest :- . . Phase . Transformations. Structure-Property Relationships. What is a Virus?. Very small . Non-living particle. Made up of nucleic acid. . and proteins. Can only reproduce by infecting living cells. Do not carry out respiration, grow or develop. Structure. Viruses have an inner core which contains either RNA or DNA. Advances in Technological Developments. 16. th. February 2013. Organized . by. NH 5, MADDURUPADU, . KAVALI . -524 . 201, SPSR NELLORE DT.,. REGISTRATION FORM. National Conference on. Advances in . Program Directors, All Protocol observed. As we come to the close yet another successfully conference. Allow me to take this opportunity to thank all who made this conference a success. In particular and I wish to thank the following:. Adenovirus showing . Varicella. . zoster. virus. icosahedral shape causes chickenpox. 2. Characteristics of Viruses. Michael Specter. The New Yorker. December 3, 2007. Presented by. Patrick Wu. 20.385 Advanced Topics in . Sy. nthetic. Biology. May 10, 2011. Background of Viruses. Genetic material within protein capsid. Switch to LPV/r + RAL KITE Study KITE Study: switch to LPV/r + RAL Design Age ≥ 18 years HIV+ No previous virologi c failure to PI/r-based ART HIV-1 RNA < 50 c/ml On stable (≥ 6 months) 2 NRTI + 3rd agent Switch to LPV/r + RAL KITE Study KITE Study: switch to LPV/r + RAL Design Age ≥ 18 years HIV+ No previous virologi c failure to PI/r-based ART HIV-1 RNA < 50 c/ml On stable (≥ 6 months) 2 NRTI + 3rd agent Lecture 1 and 2. Gene Therapy. Definition: . the . introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders. .. Approaches: . Replacing a mutated gene that causes disease with a healthy copy of the gene.. Transcription, translation and transport. Transcription of virus genome. In the summary of the scheme depicted . below, most . of the nucleic acid strands are . labelled. (+) . or (. −). This . labelling. Device (NFID) versus Needle. BOSS . Study. Enfuvirtide. Needle-Free Injection Device vs. Needle/Syringe. BOSS. : Study Design. Source: . Lalezari. JP, et al. . . AIDS Res Hum . Retroviruses. . . 2008;24:. /r and . Metabolic . Parameters . METABOLIK. DRV/r . versus . ATV/r . and Metabolic Parameters . METABOLIK. : . Study Design . Source. : . Aberg. JA, et al. AIDS Res Hum Retroviruses. . 2012;28:. 1184-95..